Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sarepta Therapeutics Inc (NASDAQ:SRPT)

Delayed Data
As of 3:59pm ET
 -0.37 / -1.06%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 15 analysts offering 12-month price forecasts for Sarepta Therapeutics Inc have a median target of 60.00, with a high estimate of 102.00 and a low estimate of 27.00. The median estimate represents a +73.16% increase from the last price of 34.65.

Analyst Recommendations

The current consensus among 16 polled investment analysts is to Buy stock in Sarepta Therapeutics Inc. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Aug 10

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -158.29%
Growthannually 86.68%


Growthquarterly 36.48%
Growthannually 1,875.79%
Key to the earnings and sales forecast charts.